Heterogeneity index evaluated by slope of linear regression on 18F-FDG PET/CT as a prognostic marker for predicting tumor recurrence in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Yong-il Kim
Yong Joong Kim
Jin Chul Paeng
Gi Jeong Cheon
Dong Soo Lee
June-Key Chung
Keon Wook Kang
机构：
[1] CHA University,Department of Nuclear Medicine, CHA Bundang Medical Center
[2] Seoul National University Hospital,Department of Nuclear Medicine
[3] Veterans Health Service Medical Center,Cancer Research Institute
[4] Seoul National University,Department of Biomedical Sciences
[5] Seoul National University College of Medicine,Department of Nuclear Medicine
[6] Seoul National University College of Medicine,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2017年 / 44卷
关键词：
Pancreatic cancer; Recurrence; Heterogeneity; Metabolic tumor volume; Total lesion glycolysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1995 / 2003
页数：8
相关论文
共 50 条
  • [41] Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation
    Yaprak, Onur
    Acar, Sencan
    Ertugrul, Gokhan
    Dayangac, Murat
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 10 (10) : 336 - 343
  • [42] Prognostic significance of metabolic tumor volume measured by 18F-FDG PET/CT in operable primary breast cancer
    Jahae Kim
    Su Woong Yoo
    Sae-Ryung Kang
    Sang-Geon Cho
    Jong-Ryool Oh
    Ari Chong
    Jung-Joon Min
    Hee-Seung Bom
    Jung-Han Yoon
    Ho-Chun Song
    Nuclear Medicine and Molecular Imaging, 2012, 46 (4) : 278 - 285
  • [43] Dual-phase 18F-FDG PET/CT imaging in the characterization of pancreatic lesions: does it offer prognostic information?
    Santhosh, Sampath
    Mittal, Bhagwant R.
    Bhasin, Deepak
    Rana, Surinder S.
    Bhattacharya, Anish
    Srinivasan, Radhika
    Nada, Ritambhra
    Gupta, Rajesh
    NUCLEAR MEDICINE COMMUNICATIONS, 2014, 35 (10) : 1018 - 1025
  • [44] Role of SUVmax obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation
    Hu, Si-Long
    Yang, Zhong-Yi
    Zhou, Zheng-Rong
    Yu, Xian-Jun
    Ping, Bo
    Zhang, Ying-Jian
    NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (06) : 533 - 539
  • [45] 18F-FDG PET/CT Volumetric Parameters are Associated with Tumor Grade and Metastasis in Pancreatic Neuroendocrine Tumors in von Hippel–Lindau Disease
    Kei Satoh
    Samira M. Sadowski
    William Dieckmann
    Martha Quezado
    Naris Nilubol
    Electron Kebebew
    Dhaval Patel
    Annals of Surgical Oncology, 2016, 23 : 714 - 721
  • [46] Prognostic Value of Preoperative Metabolic Tumor Volume and Total Lesion Glycolysis Measured by 18F-FDG PET/CT in Salivary Gland Carcinomas
    Ryu, In Sun
    Kim, Jae Seung
    Roh, Jong-Lyel
    Lee, Jeong Hyun
    Cho, Kyung-Ja
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (07) : 1032 - 1038
  • [47] Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in PatientsWith Renal Cell Carcinoma
    Nakajima, Reiko
    Matsuo, Yuka
    Kondo, Tsunenori
    Abe, Koichiro
    Sakai, Shuji
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (04) : E177 - E182
  • [48] Prognostic value of preoperative metabolic tumor volume measured by 18F-FDG PET/CT and MRI in patients with endometrial cancer
    Chung, Hyun Hoon
    Lee, Inki
    Kim, Hee Seung
    Kim, Jae Weon
    Park, Noh-Hyun
    Song, Yong Sang
    Cheon, Gi Jeong
    GYNECOLOGIC ONCOLOGY, 2013, 130 (03) : 446 - 451
  • [49] The exploration of quantitative intra-tumoral metabolic heterogeneity in dual-time 18F-FDG PET/CT of pancreatic cancer
    Guorong Jia
    Jian Zhang
    Rou Li
    Jianhua Yan
    Changjing Zuo
    Abdominal Radiology, 2021, 46 : 4218 - 4225
  • [50] The exploration of quantitative intra-tumoral metabolic heterogeneity in dual-time 18F-FDG PET/CT of pancreatic cancer
    Jia, Guorong
    Zhang, Jian
    Li, Rou
    Yan, Jianhua
    Zuo, Changjing
    ABDOMINAL RADIOLOGY, 2021, 46 (09) : 4218 - 4225
12345